The State Street SPDR Portfolio MSCI Global Stock Market ETF (NYSEMKT:SPGM) and iShares Core MSCI Emerging Markets ETF (NYSEMKT:IEMG) differ materially in geographic focus, sector exposure, and risk profile, despite sharing the same low expense ratio. SPGM is designed to provide broad, diversified exposure to both developed and emerging global equities, making it a core holding for many investors ...
The State Street SPDR Portfolio MSCI Global Stock Market ETF (NYSEMKT:SPGM) and iShares Core MSCI Emerging Markets ETF (NYSEMKT:IEMG) differ materially in geographic focus, sector exposure, and risk profile, despite sharing the same low expense ratio. SPGM is designed to provide broad, diversified exposure to both developed and emerging global equities, making it a core holding for many investors seeking to track the entire global market. IEMG, in contrast, narrows its focus to emerging market stocks, offering targeted access to faster-growing but potentially more volatile regions. This comparison explores how these differences play out across cost, performance, risk, and portfolio makeup. Continue reading
The Nasdaq Composite (^IXIC) is trading in the green at Friday’s open, with the index leading the major averages as legacy chipmaker Intel’s blowout earnings report reignites the AI-infrastructure trade. The Nasdaq is drawing strength from mega-cap tech and dramatic single-stock moves, even as traders monitor the Strait of Hormuz. For the week, the Nasdaq ... Nasdaq Composite Rises on Cautious Opt...
The Nasdaq Composite (^IXIC) is trading in the green at Friday’s open, with the index leading the major averages as legacy chipmaker Intel’s blowout earnings report reignites the AI-infrastructure trade. The Nasdaq is drawing strength from mega-cap tech and dramatic single-stock moves, even as traders monitor the Strait of Hormuz. For the week, the Nasdaq ... Nasdaq Composite Rises on Cautious Optimism on Tech Tailwinds but Iran Tensions Loom
Guido Mieth Bank of America analyst Michael Hartnett said Friday the classic “sleep like a baby” portfolio is tracking one of its strongest years in modern market history. The strategy, which splits assets evenly across stocks ( SPY ), bonds ( TLT ), commodities ( DBC ) and cash, is running at a 26% annualized pace in 2026, according to a BofA Securities note. That puts it just below the 27% retur...
Guido Mieth Bank of America analyst Michael Hartnett said Friday the classic “sleep like a baby” portfolio is tracking one of its strongest years in modern market history. The strategy, which splits assets evenly across stocks ( SPY ), bonds ( TLT ), commodities ( DBC ) and cash, is running at a 26% annualized pace in 2026, according to a BofA Securities note. That puts it just below the 27% return seen in 1933. What's more, Hartnett noted the 25/25/25/25 portfolio is posting its third-best outperformance versus a traditional 60/40 stock-bond portfolio in a century. Commodities have done much of the heavy lifting this year, yet remain deeply underowned in many portfolios. BofA noted private clients hold just 0.4% in gold ( GLD ) despite its 31% annualized run rate. Bank of America Securities More on the Markets Layoffs Are Accelerating Again Buy Fear And Sell Greed How To Build A $7,000/Mo Income Using BlackRock's 8% Yielding 32 CEFs U.S. resilience keeps markets buoyant despite geopolitical risks, Stoltzfus says—CNBC interview Gold slips as oil continues higher, rekindling inflation worries
Editor's note: Seeking Alpha is proud to welcome Sergey Chitsvarin as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » sturti/E+ via Getty Images Introduction TransMedics Group, Inc. ( TMDX ) is revolutionizing the...
Editor's note: Seeking Alpha is proud to welcome Sergey Chitsvarin as a new contributing analyst. You can become one too! Share your best investment idea by submitting your article for review to our editors. Get published, earn money, and unlock exclusive SA Premium access. Click here to find out more » sturti/E+ via Getty Images Introduction TransMedics Group, Inc. ( TMDX ) is revolutionizing the organ transport market with their technology and logistics and is now expanding their business to the largest organ transplant market in the US making it one of the most compelling opportunities in the MedTech sector. Moreover, the recent sell off due to slight margin pressures can be viewed as a good opportunity to buy a strong stock at a cheaper price since TransMedics' business remains largely unaffected and continues to outperform its competitors such as XVIVO (OTCMKTS:XVIPF). TransMedics Group is rapidly growing and maintaining its dominance heading into 2026 and 2027 based on its moat in technology and logistics making it a strong buy. Background To understand TransMedics and their competitive advantage, we need to review their Organ Care System ( OCS ) and the National OCS Program (NOP). OCS is the technology TMDX uses to preserve organs during transport instead of the traditional icebox, which has been the industry standard since the late 1960s. The OCS technology keeps organs in a living, functioning state during transport, which not only increases the chances of a successful transplant but also allows for transplant of organs donated after circulatory death (DCD). Donor Organ Utilization Comparison between TransMedics OCS technology and traditional cold storage. (Source: TransMedics Group Inc. Clinical Trial Data (OCS Lung EXPAND Trial, OCS Heart EXPAND Trial, OCS DCD Heart Trial)) The National OCS Program (NOP) is TransMedics’ end-to-end organ retrieval and transport service which includes their own clinical teams, a fleet of 22 aircraft representing 80% of air ...
TexBr/iStock via Getty Images When investors look at insurers, they often see large balance sheets, generous dividends, and stable businesses. At first, Intact Financial ( IFCZF )( IFC:CA ), Great-West Lifeco ( GWLIF )( GWO:CA ), Manulife ( MFC )( MFC:CA ), and Sun Life ( SLF )( SLF:CA ) look like they belong in the same bucket. But when digging deeper, there are differences to consider. These fou...
TexBr/iStock via Getty Images When investors look at insurers, they often see large balance sheets, generous dividends, and stable businesses. At first, Intact Financial ( IFCZF )( IFC:CA ), Great-West Lifeco ( GWLIF )( GWO:CA ), Manulife ( MFC )( MFC:CA ), and Sun Life ( SLF )( SLF:CA ) look like they belong in the same bucket. But when digging deeper, there are differences to consider. These four insurers don’t grow the same way, they don’t take the same risks, and they won’t appeal to the same type of investor. One dominates property and casualty insurance with disciplined underwriting. One leans more toward steady retirement and wealth businesses. One offers more upside through Asia. One has built a more balanced platform across insurance, group benefits, and asset management. On the surface, they all look solid. Under the hood, each has a very different personality. That’s why this is such a useful stock battle. It’s not really about finding a “perfect” insurer. It’s about understanding which one fits your portfolio best. If we turn this into a ranking of the best Canadian insurance stocks for dividend growth investors, this is where I land: Intact Financial first, Sun Life second, Great-West Lifeco third, and Manulife fourth. That ranking reflects the full picture: business model, earnings resilience, growth profile, and how comfortably each insurer fits inside a long-term dividend growth portfolio. Four Insurers, Four Different Engines All four companies operate in financial services, but they don’t rely on the same models. Intact Financial is the one that stands out from the list. While the others are mostly tied to life insurance, wealth, and retirement products, Intact is a property and casualty insurer. It operates across Canada, the U.S., and the U.K./Ireland through brokers, direct-to-consumer brands like Belairdirect, and commercial platforms. This is a business built on underwriting discipline, claims management, pricing accuracy, and risk selection. ...